Publikationen, an denen er mitarbeitet Pablo Berlanga (2)

2017

  1. Deletion of 11q in neuroblastomas drives sensitivity to PARP inhibition

    Clinical Cancer Research, Vol. 23, Núm. 22, pp. 6875-6887

2016

  1. miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis

    Molecular Oncology, Vol. 10, Núm. 7, pp. 1043-1053